USE OF DALBAVANCIN IN THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN THE SPANISH HOSPITAL SETTING: A COMPARATIVE COST ANALYSIS

被引：0
|
作者：
Hernandez, I [1 ]
Carcedo, D. [1 ]
Sabaniego, J. [2 ]
Rossello, I [2 ]
Jimenez, A. [3 ]
机构：
[1] Hygeia, Madrid, Spain
[2] Angelini Pharma Espana SLU, Barcelona, Spain
[3] Hosp Univ Virgen de las Nieves, Granada, Spain
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE669
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [1] USE OF DALBAVANCIN IN THE TREATMENT OF PEDIATRIC ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN THE SPANISH HOSPITAL SETTING: A COMPARATIVE COST ANALYSIS
    Rios, M.
    Carcedo, D.
    Sabaniego, J.
    Rossello, I
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S116 - S116
  • [2] A COMPARATIVE COST ANALYSIS BETWEEN DALBAVANCIN, ORITAVANCIN AND DELAFLOXACIN FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN SPAIN
    Rios, M.
    Carcedo, D.
    Sabaniego, J.
    Rossello, I
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S86 - S86
  • [3] Dalbavancin for the treatment of acute bacterial skin and skin structure infections
    Ramdeen, Sheena
    Boucher, Helen W.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (13) : 2073 - 2081
  • [4] The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs)
    Soriano, Alex
    Rossolini, Gian Maria
    Pea, Federico
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (05) : 415 - 422
  • [5] Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
    Scott, Lesley J.
    [J]. DRUGS, 2015, 75 (11) : 1281 - 1291
  • [6] Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
    Lesley J. Scott
    [J]. Drugs, 2015, 75 : 1281 - 1291
  • [7] New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
    Juul, Janelle J.
    Mullins, Caitlin F.
    Peppard, William J.
    Huang, Angela M.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 225 - 232
  • [8] Dalbavancin in the treatment of acute bacterial skin and skin structure and other infections: a safety evaluation
    Righi, Elda
    Visentin, Alessandro
    Meroi, Marco
    Carrara, Elena
    Tacconelli, Evelina
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (09) : 1171 - 1181
  • [9] Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
    Leuthner, Kimberly D.
    Buechler, Kristin A.
    Kogan, David
    Saguros, Agafe
    Lee, H. Stephen
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 931 - 940
  • [10] Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections
    Rappo, Urania
    Gonzalez, Pedro L.
    Puttagunta, Sailaja
    Akinapelli, Karthik
    Keyloun, Katelyn
    Gillard, Patrick
    Liu, Yan
    Dunne, Michael W.
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 17 : 60 - 65
12345